Using blood tests to guide antibiotic treatment for COPD flare-ups
Part of Lungs & breathing clinical trials.
This study tests whether measuring two blood markers (MxA and CRP) can help doctors decide if antibiotics or antiviral drugs are needed for a COPD flare-up. It aims to reduce unnecessary antibiotic use while still treating infections effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 40 years or older
- You are a current or former smoker with at least 10 pack-years of smoking history
- You have been diagnosed with mild to severe COPD
- You are currently having a COPD flare-up that is mild to moderate in severity
- You have not had certain recent treatments or conditions (like interferon therapy, vaccines, or major inflammation events)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a Chinese herbal medicine called Xuanfei Jiangzhuo to see if it helps people with COPD who are having a flare-up caused by the flu. The goal is to improve breathing and speed up recovery.
This study looks at whether simple blood tests can help doctors decide if you need antibiotics and steroids for a COPD flare-up. Participating may help tailor your treatment and avoid unnecessary medications.
This trial checks whether using fast test results (PCR from samples, a blood marker called procalcitonin, and sputum appearance) can safely reduce how long you need antibiotics during a severe COPD flare. It may help you receive fewer days of antibiotics while still controlling the infection risk.
This study is testing a personalized approach to how long antibiotics are given for COPD flare-ups. It aims to see if matching antibiotic duration to each patient's needs is safe and effective, potentially avoiding unnecessary antibiotics.
This trial tests whether giving a special antibiotic treatment to clear a common lung fungus (Pneumocystis jirovecii) can reduce how often COPD flare-ups happen. If you qualify, this might help you have fewer severe episodes.
This trial tests if a quick blood test (C-reactive protein, CRP) and a patient leaflet can help doctors prescribe antibiotics only when needed for adults with respiratory tract infections. It aims to reduce unnecessary antibiotic use.
Hear when a new Acute Exacerbation Chronic Obstructive Pulmonary Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.